These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses. Hemmingsen B; Christensen LL; Wetterslev J; Vaag A; Gluud C; Lund SS; Almdal T BMJ; 2012 Apr; 344():e1771. PubMed ID: 22517929 [TBL] [Abstract][Full Text] [Related]
9. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. Boussageon R; Bejan-Angoulvant T; Saadatian-Elahi M; Lafont S; Bergeonneau C; Kassaï B; Erpeldinger S; Wright JM; Gueyffier F; Cornu C BMJ; 2011 Jul; 343():d4169. PubMed ID: 21791495 [TBL] [Abstract][Full Text] [Related]
10. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067 [TBL] [Abstract][Full Text] [Related]
12. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Hemmingsen B; Sonne DP; Metzendorf MI; Richter B Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986 [TBL] [Abstract][Full Text] [Related]
13. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes. Kunutsor SK; Balasubramanian VG; Zaccardi F; Gillies CL; Aroda VR; Seidu S; Khunti K Diabetes Obes Metab; 2024 Jun; 26(6):2069-2081. PubMed ID: 38409644 [TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus. Hemmingsen B; Sonne DP; Metzendorf MI; Richter B Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279 [TBL] [Abstract][Full Text] [Related]
15. Perioperative glycaemic control for diabetic patients undergoing surgery. Buchleitner AM; Martínez-Alonso M; Hernández M; Solà I; Mauricio D Cochrane Database Syst Rev; 2012 Sep; (9):CD007315. PubMed ID: 22972106 [TBL] [Abstract][Full Text] [Related]
16. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419 [TBL] [Abstract][Full Text] [Related]
17. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069 [TBL] [Abstract][Full Text] [Related]
18. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus. Hemmingsen B; Metzendorf MI; Richter B Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147 [TBL] [Abstract][Full Text] [Related]
19. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Ray KK; Seshasai SR; Wijesuriya S; Sivakumaran R; Nethercott S; Preiss D; Erqou S; Sattar N Lancet; 2009 May; 373(9677):1765-72. PubMed ID: 19465231 [TBL] [Abstract][Full Text] [Related]